Article
Spectrum of MTHFR gene SNPs C677T and A1298C: a study among 23 population groups of India.
Biochemical and Molecular Lab, Department of Anthropology, University of Delhi, Delhi, 110007, India.
Molecular Biology Reports (impact factor:
2.93).
12/2011;
39(4):5025-31.
DOI:10.1007/s11033-011-1299-8
Source: PubMed
-
Article: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
[show abstract] [hide abstract]
ABSTRACT: Hyperhomocysteinaemia has been identified as a risk factor for cerebrovascular, peripheral vascular and coronary heart disease. Elevated levels of plasma homocysteine can result from genetic or nutrient-related disturbances in the trans-sulphuration or re-methylation pathways for homocysteine metabolism. 5, 10-Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the predominant circulatory form of folate and carbon donor for the re-methylation of homocysteine to methionine. Reduced MTHFR activity with a thermolabile enzyme has been reported in patients with coronary and peripheral artery disease. We have identified a common mutation in MTHFR which alters a highly-conserved amino acid; the substitution occurs at a frequency of approximately 38% of unselected chromosomes. The mutation in the heterozygous or homozygous state correlates with reduced enzyme activity and increased thermolability in lymphocyte extracts; in vitro expression of a mutagenized cDNA containing the mutation confirms its effect on thermolability of MTHFR. Finally, individuals homozygous for the mutation have significantly elevated plasma homocysteine levels. This mutation in MTHFR may represent an important genetic risk factor in vascular disease.Nature Genetics 06/1995; 10(1):111-3. · 35.53 Impact Factor -
Article: Biological and clinical implications of the MTHFR C677T polymorphism.
[show abstract] [hide abstract]
ABSTRACT: The enzyme methylenetetrahydrofolate reductase (MTHFR) directs folate species either to DNA synthesis or to homocysteine (Hcy) remethylation. The common MTHFR C677T polymorphism affects the activity of the enzyme and hence folate distribution. Under conditions of impaired folate status, the homozygous TT genotype has been regarded as harmful because it is associated with a high concentration of plasma total Hcy, increased risk of neural tube defects and colorectal neoplasias, and can also predispose individuals to adverse effects from drugs with antifolate effects. The MTHFR C677T polymorphism shows no consistent correlation with cardiovascular risk and longevity but, in combination with positive folate balance, the TT genotype is associated with decreased risk of colorectal neoplasias. Because of the high prevalence of this polymorphism in most populations, the TT variant might represent an ancestral genetic adaptation to living constraints (tissue injury or unbalanced vitamin intake) that has become a determinant of disease profiles in modern times.Trends in Pharmacological Sciences 05/2001; 22(4):195-201. · 10.93 Impact Factor -
Article: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.
[show abstract] [hide abstract]
ABSTRACT: Previous studies have suggested that hyperhomocysteinemia may be a risk factor for venous thrombosis. To assess the risk of venous thrombosis associated with hyperhomocysteinemia, we studied plasma homocysteine levels in patients with a first episode of deep-vein thrombosis and in normal control subjects. We measured plasma homocysteine levels in 269 patients with a first, objectively diagnosed episode of deep-vein thrombosis and in 269 healthy controls matched to the patients according to age and sex. Hyperhomocysteinemia was defined as a plasma homocysteine level above the 95th percentile in the control group (18.5 micromol per liter). Of the 269 patients, 28 (10 percent) had plasma homocysteine levels above the 95th percentile for the controls, as compared with 13 of the controls (matched odds ratio, 2.5; 95 percent confidence interval, 1.2 to 5.2). The association between elevated homocysteine levels and venous thrombosis was stronger among women than among men and increased with age. The exclusion of subjects with other established risk factors for thrombosis (e.g., a deficiency of protein C, protein S, or antithrombin; resistance to activated protein C; pregnancy or recent childbirth; or oral-contraceptive use) did not materially affect the risk estimates. High plasma homocysteine levels are a risk factor for deep-vein thrombosis in the general population.New England Journal of Medicine 04/1996; 334(12):759-62. · 53.30 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
23 Indian caste
A1298C single nucleotide polymorphisms
African populations
complex disorders
Dravidian-speaking tribes
east India
Elevated homocysteine
foetus
geographical regions
highest
Indo-European tongue
major linguistic groups
methylenetetrahydrofolate reductase
MTHFR homozygous genotype 677TT
mutant alleles
north Indian populations
risk factor
south India
two mutant alleles
world populations